Luteinizing hormone-releasing hormone in undifferentiated and differentiated SK-N-SH human neuroblastoma cells

Neuropeptides

Volumn 30, Issue 1, 1996, Pages 87-94

  Ratka, A ^a   Flores, B M ^a   Mambourg, S E ^a   Torian, B E ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; MESSENGER RNA; RETINOIC ACID;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA; PRIORITY JOURNAL;

EID: 0029918917     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90060-8     Document Type: Article

References (34)

1. Silverman, A. The gonadotropin-releasing hormone (GnRH) neuronal systems: immunocytochemistry. In: The physiology of reproduction, E. Knobil and J. D. Neill, eds. (New York: Raven Press), 1988: 1283-1304.
2. Matsuo, H., Baba, Y., Nair, R. M. G., Arimura, A. and Schally, A. V. Structure of the porcine LH- and FSH-releasing hormone. I. Proposed Aminoacid sequence. Biochem. Biophys. Res. Commun. 1972; 43: 1334-1339.
3. Berglund L. A. and Simpkins, J. W. Alterations in brain opiate receptor mechanisms on proestrous afternoon. Neuroendocrinology 1988; 48: 394-400.
4. Berglund, L. A., H. Derendorf, H., and Simpkins, J. W. Desensitization of brain opiate receptors mechanisms by gonadal steroid treatment which stimulate LH secretion. Endocrinology 1988; 22: 2718-2726.
5. Ratka, A. and Simpkins, J. W. (1990). A modulatory role for luteinizing hormone-releasing hormone in nociceptive responses of female rats. Endocrinology 1990; 127: 667-673.
6. Kazmi, S. M. I. and Mishra, R. K. Opioid receptors in human neuroblastoma SH-SY5Y cells: evidence for distinct morphine (μ) and enkephalin (δ) binding sites. Biochem. Biophys. Res. Commun. 1986; 137: 813-820.
7. Pahlman S., Ruusala, A. I., Abrahamsson, L., Mattsson, M. E. K and Esscher, T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: comparison with phorbol esterinduced differentiation. Cell Differ. 1984; 14: 135-144.
8. Ross, R. A., Spengler, B. A., and Biedler, J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 1983; 71: 741-747.
9. Sidell, N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J. Natl. Cancer Inst. 1982; 68: 589-593.
10. Sidell N., Altman, A., Haussler, M. R., and Seeger, R. C. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp. Cell Res. 1983; 148: 21-30.
11. Zadina, J. E., Chang, S. L., Ge, L. J., and Kastin, A. J. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmaco. Exp. Ther. 1992; 265: 254-262.
12. Lovat, P. E., Pearson, A. D. J., Malcolm, A., and Redfern, C. P. F. Retinoic acid receptor expression during the in vitro differentiation of human neuroblastoma. Neurosci. Letters 1993; 162: 109-113.
13. Wuarin, L., Chang, B., Wada, R., and N. Sidell, N. Retinoic acid up-regulates nuclear retinoic acid receptor-α expression in human neuroblastoma cells. Int. J. Cancer 1994; 56: 840-845.
14. Marshall, G. M., Cheung, B., Stacey, K. P., Norris, M. D., and Haber, M. Regulation of retinoic acid receptor alpha expression in human neuroblastoma cell lines and tumor tissue. Anticancer Res. 1993; 13: 437-442.
15. Clagett-Dame, M., Verbalen, T. J., Biedler, J. L., and Repa, J. J. Identification and characterization of all-trans-retinoic acid receptor transcripts and receptor protein in human neuroblastoma cells. Arch. Bioch. Biophys. 1993; 300: 684-693.
16. Stephanou, A., Melino, G., Knight, R. A., Annicchiarico-Petruzzelli, M. N., Sarlis, J., Finazzi-Agro, A., and Lightman, S. L. Interleukin-6 and corticotrophin-releasing hormone mRNA are modulated during differentiation of human neuroblastoma cells. Neuropeptides 1992; 23: 45-49.
17. Stephanou, A., Knight, R. A., DeLaurenzi, V., Melino, G., and Lightman, S. L. Expression of pre-opiomelanocortin (POMC) mRNA in undifferentiated and in vitro differentiated human neuroblastoma cell lines. Prog. Clin. Biol. Res. 1991; 366: 173-180.
18. Georg, B., Wulff, B. S., and J. Fahrenkrug, J. Characterization of the effects of retinoic acid on vasoactive intestinal polypeptide gene expression in neuroblastoma cells. Endocrinology 1994; 135: 1455-1463.
19. Melino, G., Stephanou, A., Annicchiarico-Petruzzelli, M., Knight, R., Finazzi-Agro, A., and Lightman, S. L. Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-2. Neurosci. Letters 1993; 151: 187-191.
20. Hall, A. K., Chen, S. C., Hempstead, J. L., and Morgan, J. I. Retinoic acid regulates thymosin β 10 levels in rat neuroblastoma cells. J. Neurochem. 1991; 56: 462-468.
21. Hsu, S. M., Raine, L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.;. Histochem. Cytochem. 1981; 29: 577-580.
22. Benoit, R., Ling, N., Brazeau, P., Lavielle, S., and Guillemin, R. Strategies for antibody production and radioimmunoassays. In: Neuromethods, vol. 6: Peptides, Edited by: Boulton, A. A., Baker, G. B., and Pittman, Q. J. The Human Press, Inc., 1987; 43-72.
23. Adelman, J. P., Mason, A. J, Hayflick, J. S., and Seeburg, P. H. Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. Proc. Natl. Acad. Sci. USA 1986; 83: 179-183.
24. Mellon, P. L., Windle, J. J., Goldsmith, P. C., Padula, C. A., Roberts, J. L., and Weiner, R. I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 1990; 5: 1-10.
25. Wetsel, W. C., Mellan, P. L., Weiner, R. I., and Negro-Vilar, A. Metabolism of pro-luteinizing hormone-releasing hormone in immortalized hypothalamic neurons. Endocrinology 1991; 129: 1584-1595.
26. Ratka, A., Torian, B. E., Flores, B. M., Simpkins, J. W., and Berglund, L A. Molecular characterization of luteinizing hormone-releasing hormone in opioid-responsive neuroblastoma cells. 23rd Annual Meeting of the Society for Neuroscience, 1993, Abstr. 642.14.
27. Zhou, J., Holtzman, D. M., Weiner, R. I., and Mobley, W. C. Expression of TrkA confers neuron-like responsiveness to nerve growth factor on an immortalized hypothalamic cell line. Proc. Natl. Acad. Sci. USA 1994; 91: 3824-3828.
28. Georg, B., Wulff, B. S., and Fahrenkrug, J. Characterization of the effects of retinoic acid on vasoactive intestinal polypeptide gene expression in neuroblastoma cells. Endocrinology 1994; 135: 1455-1463.
29. Agoston, D. V., Colburn, S., Krajniak, K. G., and Waschek, J. A. Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells. Neurosci. Letters 1992; 139: 213-216.
30. Heideveld, M., Ayoubi, T. A., van de Wiel, M. H., Martens, G. J., and Durston, A. J. Proopiomelanocortin gene expression as a neural marker during the embryonic development of Xenopus laevis. Differentiation 1993; 52: 195-200.
31. Biedler, J. L., Helson, L., and Spengler, B. A. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973; 33: 2643-2652.
32. Guigere, V., Ong, E. S., Sequi, P., and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624-629.
33. Leroy, P., Krust, A., Kastner, P., Mendelsohn, C., Zelent, A., and Chambon, P. Retinoic acid receptors. In: Morris Kay G, ed. Retinoids in normal development and teratogenesis. Oxford: Oxford University Press, 1992: 7-25.
34. Zelent, R., Krust, A., Petkovich, M., Kastner, P., and Chambon, P. Cloning of murine α and β retinoic receptors and a novel receptor γ predominantly expressed in skin. Nature 1989; 339: 714-717